| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 3.73e-07 | 50 | 113 | 6 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 5.31e-07 | 53 | 113 | 6 | GO:0016859 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate binding | 7.49e-06 | 48 | 113 | 5 | GO:0032266 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 6.19e-05 | 38 | 113 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 1.01e-04 | 43 | 113 | 4 | GO:0043548 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.88e-04 | 20 | 113 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.89e-04 | 279 | 113 | 8 | GO:0005096 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-5-phosphate binding | 2.88e-04 | 23 | 113 | 3 | GO:0010314 | |
| GeneOntologyMolecularFunction | actin filament binding | 3.11e-04 | 227 | 113 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.37e-04 | 230 | 113 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | enzyme activator activity | DAB2IP RGPD8 SRC RGPD1 ADGRB3 TBC1D25 LCK PSME4 SH3PXD2A RGPD3 SIPA1L2 RGPD5 | 3.43e-04 | 656 | 113 | 12 | GO:0008047 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.59e-04 | 118 | 113 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | alpha-actinin binding | 7.07e-04 | 31 | 113 | 3 | GO:0051393 | |
| GeneOntologyMolecularFunction | phospholipase binding | 7.77e-04 | 32 | 113 | 3 | GO:0043274 | |
| GeneOntologyMolecularFunction | isomerase activity | 7.88e-04 | 192 | 113 | 6 | GO:0016853 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 8.69e-04 | 8 | 113 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 9.49e-04 | 199 | 113 | 6 | GO:1901981 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate binding | 1.10e-03 | 36 | 113 | 3 | GO:0070273 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.10e-03 | 36 | 113 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.25e-03 | 210 | 113 | 6 | GO:0019903 | |
| GeneOntologyMolecularFunction | protein domain specific binding | DAB2IP SHANK1 CACNA1C ILK SRC INSR U2AF2 IRS1 LCK L3MBTL1 MYPN AFDN ABCC2 | 1.35e-03 | 875 | 113 | 13 | GO:0019904 |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 1.39e-03 | 10 | 113 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.41e-03 | 145 | 113 | 5 | GO:0004713 | |
| GeneOntologyMolecularFunction | actin binding | 1.61e-03 | 479 | 113 | 9 | GO:0003779 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 1.73e-03 | 42 | 113 | 3 | GO:0051721 | |
| GeneOntologyMolecularFunction | actinin binding | 1.85e-03 | 43 | 113 | 3 | GO:0042805 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 2.13e-03 | 599 | 113 | 10 | GO:0050839 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 2.24e-03 | 46 | 113 | 3 | GO:0004715 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 2.36e-03 | 507 | 113 | 9 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 2.36e-03 | 507 | 113 | 9 | GO:0030695 | |
| GeneOntologyMolecularFunction | cytidine deaminase activity | 2.38e-03 | 13 | 113 | 2 | GO:0004126 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 2.97e-03 | 172 | 113 | 5 | GO:0044325 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 3.18e-03 | 15 | 113 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 3.19e-03 | 52 | 113 | 3 | GO:0042169 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CACNA1C MYH2 MYH8 MYH13 MYO10 MTSS1 OBSCN PTPRT MYPN COBL AFDN IQCJ-SCHIP1 MTCL1 PLS3 | 3.65e-03 | 1099 | 113 | 14 | GO:0008092 |
| GeneOntologyMolecularFunction | phosphatase binding | 3.92e-03 | 264 | 113 | 6 | GO:0019902 | |
| GeneOntologyMolecularFunction | phospholipid binding | 3.95e-03 | 548 | 113 | 9 | GO:0005543 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.64e-06 | 38 | 109 | 5 | GO:0000413 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 3.35e-06 | 20 | 109 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 9.67e-06 | 54 | 109 | 5 | GO:0018208 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.18e-05 | 9 | 109 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | cellular component maintenance | 1.60e-05 | 101 | 109 | 6 | GO:0043954 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.68e-05 | 10 | 109 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | cell junction maintenance | 2.41e-05 | 65 | 109 | 5 | GO:0034331 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 3.95e-05 | 13 | 109 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 5.01e-05 | 14 | 109 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 7.87e-05 | 134 | 109 | 6 | GO:0010906 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | DAB2IP SHANK1 SEMA6C SEMA4D ILK SRC ADGRB3 LAMA2 PAK6 TTC3 NEGR1 MYPN COBL AFDN | 1.05e-04 | 819 | 109 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | DAB2IP SHANK1 SEMA6C SEMA4D ILK SRC ADGRB3 LAMA2 PAK6 TTC3 NEGR1 MYPN COBL AFDN | 1.15e-04 | 826 | 109 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 1.46e-04 | 150 | 109 | 6 | GO:0050773 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | RGPD8 SRC INSR ATG2B RGPD1 GAL3ST4 IRS1 MYOF RGPD3 PYGL GAPDHS WIPI2 | 1.58e-04 | 646 | 109 | 12 | GO:0005975 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | GP6 SEMA4D SDK2 MIA3 ITCH ILK MYO10 SRC LCK PTPRT SVEP1 JAM2 HMCN1 NEGR1 MYPN AFDN | 1.67e-04 | 1077 | 109 | 16 | GO:0098609 |
| GeneOntologyBiologicalProcess | glycogen metabolic process | 1.81e-04 | 99 | 109 | 5 | GO:0005977 | |
| GeneOntologyBiologicalProcess | platelet activation | 1.94e-04 | 158 | 109 | 6 | GO:0030168 | |
| GeneOntologyBiologicalProcess | glucan metabolic process | 1.99e-04 | 101 | 109 | 5 | GO:0044042 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 1.99e-04 | 301 | 109 | 8 | GO:0048588 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 2.28e-04 | 231 | 109 | 7 | GO:0006109 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | DAB2IP SHANK1 SEMA6C SEMA4D ILK ADGRB3 LAMA2 PAK6 TTC3 NEGR1 MYPN COBL AFDN | 3.15e-04 | 802 | 109 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | glucose metabolic process | 3.18e-04 | 244 | 109 | 7 | GO:0006006 | |
| GeneOntologyBiologicalProcess | actin filament-based process | AKAP6 SHANK1 CACNA1C MYH2 MYH8 ILK SRC MTSS1 OBSCN DNAI3 HMCN1 MYPN COBL PLS3 | 3.19e-04 | 912 | 109 | 14 | GO:0030029 |
| GeneOntologyBiologicalProcess | energy reserve metabolic process | 3.49e-04 | 114 | 109 | 5 | GO:0006112 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 3.98e-04 | 421 | 109 | 9 | GO:0048638 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular DNA | 4.09e-04 | 6 | 109 | 2 | GO:0044355 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular nucleic acids | 4.09e-04 | 6 | 109 | 2 | GO:0099046 | |
| GeneOntologyBiologicalProcess | positive regulation of glycolytic process | 4.75e-04 | 29 | 109 | 3 | GO:0045821 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide catabolic process | 4.75e-04 | 29 | 109 | 3 | GO:0030813 | |
| GeneOntologyBiologicalProcess | positive regulation of purine nucleotide catabolic process | 4.75e-04 | 29 | 109 | 3 | GO:0033123 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 5.14e-04 | 124 | 109 | 5 | GO:0007229 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | DAB2IP SHANK1 SEMA6C SEMA4D ILK LIMD1 MYO10 SRC ADGRB3 LAMA2 PAK6 TTC3 NEGR1 MYPN COBL AFDN | 5.28e-04 | 1194 | 109 | 16 | GO:0000902 |
| GeneOntologyBiologicalProcess | polysaccharide metabolic process | 5.53e-04 | 126 | 109 | 5 | GO:0005976 | |
| GeneOntologyBiologicalProcess | leukotriene transport | 5.71e-04 | 7 | 109 | 2 | GO:0071716 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | DAB2IP GP6 SRC INSR MTSS1 IRS1 GIGYF1 LCK PTPRT SVEP1 MYOF REPS2 | 5.87e-04 | 747 | 109 | 12 | GO:0007169 |
| GeneOntologyBiologicalProcess | muscle structure development | AKAP6 ILK MTSS1 OBSCN ADGRB3 LAMA2 JAM2 MYOF NEGR1 TLL2 KAT8 MYPN ZFHX3 | 5.97e-04 | 858 | 109 | 13 | GO:0061061 |
| GeneOntologyBiologicalProcess | carbohydrate catabolic process | 6.14e-04 | 196 | 109 | 6 | GO:0016052 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 6.83e-04 | 132 | 109 | 5 | GO:0043255 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 8.67e-06 | 8 | 114 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | myosin filament | 9.71e-06 | 25 | 114 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.84e-05 | 10 | 114 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | caveola | 3.28e-05 | 111 | 114 | 6 | GO:0005901 | |
| GeneOntologyCellularComponent | annulate lamellae | 5.50e-05 | 14 | 114 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | muscle myosin complex | 8.40e-05 | 16 | 114 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | cell-cell junction | AKAP6 MYH2 ILK LIMD1 MTSS1 OBSCN LCK TEC JAM2 HMCN1 AFDN ABCC2 | 9.35e-05 | 591 | 114 | 12 | GO:0005911 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.21e-04 | 18 | 114 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | plasma membrane raft | 1.56e-04 | 147 | 114 | 6 | GO:0044853 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.68e-04 | 20 | 114 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | insulin receptor complex | 1.76e-04 | 4 | 114 | 2 | GO:0005899 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.96e-04 | 21 | 114 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | myosin complex | 3.03e-04 | 59 | 114 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin II complex | 4.68e-04 | 28 | 114 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | myofibril | 7.52e-04 | 273 | 114 | 7 | GO:0030016 | |
| GeneOntologyCellularComponent | membrane raft | 8.37e-04 | 362 | 114 | 8 | GO:0045121 | |
| GeneOntologyCellularComponent | anchoring junction | AKAP6 MYH2 ILK LIMD1 SRC MTSS1 OBSCN LCK TEC JAM2 HMCN1 SH3PXD2A AFDN ABCC2 | 8.63e-04 | 976 | 114 | 14 | GO:0070161 |
| GeneOntologyCellularComponent | membrane microdomain | 8.68e-04 | 364 | 114 | 8 | GO:0098857 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.07e-03 | 290 | 114 | 7 | GO:0043292 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 1.22e-03 | 576 | 114 | 10 | GO:0015629 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.71e-03 | 157 | 114 | 5 | GO:0098839 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.75e-03 | 503 | 114 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.75e-03 | 94 | 114 | 4 | GO:0044291 | |
| GeneOntologyCellularComponent | dendritic growth cone | 1.88e-03 | 12 | 114 | 2 | GO:0044294 | |
| GeneOntologyCellularComponent | nuclear pore | 2.28e-03 | 101 | 114 | 4 | GO:0005643 | |
| GeneOntologyCellularComponent | P-body | 2.36e-03 | 102 | 114 | 4 | GO:0000932 | |
| GeneOntologyCellularComponent | sarcomere | 2.46e-03 | 249 | 114 | 6 | GO:0030017 | |
| MousePheno | abnormal morula morphology | 2.16e-05 | 26 | 90 | 4 | MP:0012058 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 6.46e-05 | 107 | 90 | 6 | MP:0003694 | |
| MousePheno | increased hepatocellular carcinoma incidence | 8.61e-05 | 70 | 90 | 5 | MP:0003331 | |
| MousePheno | abnormal blastocyst hatching | 8.76e-05 | 113 | 90 | 6 | MP:0003693 | |
| MousePheno | abnormal preimplantation embryo development | 1.15e-04 | 171 | 90 | 7 | MP:0009781 | |
| MousePheno | hyperglycinuria | 1.22e-04 | 3 | 90 | 2 | MP:0030616 | |
| MousePheno | abnormal hepatobiliary system morphology | SHANK1 SEMA6C CACNA1C ITCH RGPD8 STAG1 MYO10 INSR MTSS1 RGPD1 FAH PSME4 NEGR1 SH3PXD2A KAT8 RGPD3 SLC13A5 PYGL AFDN ABCC2 SUFU REXO1L1P | 1.28e-04 | 1476 | 90 | 22 | MP:0002138 |
| MousePheno | elevated level of mitotic sister chromatid exchange | 1.36e-04 | 16 | 90 | 3 | MP:0003701 | |
| MousePheno | abnormal liver morphology | SHANK1 SEMA6C CACNA1C RGPD8 STAG1 MYO10 INSR MTSS1 RGPD1 FAH PSME4 NEGR1 SH3PXD2A KAT8 RGPD3 SLC13A5 PYGL AFDN ABCC2 SUFU REXO1L1P | 2.39e-04 | 1433 | 90 | 21 | MP:0000598 |
| MousePheno | abnormal liver size | SHANK1 SEMA6C CACNA1C INSR MTSS1 FAH NEGR1 SH3PXD2A PYGL AFDN ABCC2 SUFU | 2.48e-04 | 562 | 90 | 12 | MP:0004848 |
| Domain | Grip | 3.51e-07 | 11 | 109 | 4 | SM00755 | |
| Domain | GRIP | 3.51e-07 | 11 | 109 | 4 | PF01465 | |
| Domain | Ran_BP1 | 5.24e-07 | 12 | 109 | 4 | PF00638 | |
| Domain | RANBD1 | 5.24e-07 | 12 | 109 | 4 | PS50196 | |
| Domain | GRIP_dom | 5.24e-07 | 12 | 109 | 4 | IPR000237 | |
| Domain | GRIP | 5.24e-07 | 12 | 109 | 4 | PS50913 | |
| Domain | RanBD | 7.54e-07 | 13 | 109 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 7.54e-07 | 13 | 109 | 4 | IPR000156 | |
| Domain | Rab_bind | 6.65e-06 | 7 | 109 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 6.65e-06 | 7 | 109 | 3 | IPR032023 | |
| Domain | RICIN | 2.02e-05 | 28 | 109 | 4 | SM00458 | |
| Domain | RICIN_B_LECTIN | 2.02e-05 | 28 | 109 | 4 | PS50231 | |
| Domain | - | 2.25e-05 | 10 | 109 | 3 | 1.10.220.60 | |
| Domain | Ricin_B_lectin | 2.68e-05 | 30 | 109 | 4 | IPR000772 | |
| Domain | IQ | 5.92e-05 | 71 | 109 | 5 | PF00612 | |
| Domain | Myosin_head_motor_dom | 6.95e-05 | 38 | 109 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 6.95e-05 | 38 | 109 | 4 | PS51456 | |
| Domain | Myosin_head | 6.95e-05 | 38 | 109 | 4 | PF00063 | |
| Domain | MYSc | 6.95e-05 | 38 | 109 | 4 | SM00242 | |
| Domain | IGc2 | 7.11e-05 | 235 | 109 | 8 | SM00408 | |
| Domain | Ig_sub2 | 7.11e-05 | 235 | 109 | 8 | IPR003598 | |
| Domain | Myosin_N | 8.36e-05 | 15 | 109 | 3 | PF02736 | |
| Domain | Myosin_N | 8.36e-05 | 15 | 109 | 3 | IPR004009 | |
| Domain | IQ | 1.11e-04 | 81 | 109 | 5 | SM00015 | |
| Domain | ig | 1.25e-04 | 190 | 109 | 7 | PF00047 | |
| Domain | Immunoglobulin | 1.25e-04 | 190 | 109 | 7 | IPR013151 | |
| Domain | Myosin_tail_1 | 1.48e-04 | 18 | 109 | 3 | PF01576 | |
| Domain | Myosin_tail | 1.48e-04 | 18 | 109 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.75e-04 | 19 | 109 | 3 | IPR027401 | |
| Domain | - | 1.75e-04 | 19 | 109 | 3 | 4.10.270.10 | |
| Domain | IQ_motif_EF-hand-BS | 1.83e-04 | 90 | 109 | 5 | IPR000048 | |
| Domain | PH_dom-like | 1.96e-04 | 426 | 109 | 10 | IPR011993 | |
| Domain | Multidrug-R_assoc | 2.01e-04 | 4 | 109 | 2 | IPR005292 | |
| Domain | IQ | 2.13e-04 | 93 | 109 | 5 | PS50096 | |
| Domain | PROTEIN_KINASE_TYR | 2.60e-04 | 97 | 109 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.60e-04 | 97 | 109 | 5 | IPR008266 | |
| Domain | SH3 | 2.76e-04 | 216 | 109 | 7 | SM00326 | |
| Domain | SH3 | 2.76e-04 | 216 | 109 | 7 | PS50002 | |
| Domain | SH3_domain | 3.08e-04 | 220 | 109 | 7 | IPR001452 | |
| Domain | - | 4.76e-04 | 391 | 109 | 9 | 2.30.29.30 | |
| Domain | Ig-like_dom | 7.23e-04 | 503 | 109 | 10 | IPR007110 | |
| Domain | IG | 8.06e-04 | 421 | 109 | 9 | SM00409 | |
| Domain | Ig_sub | 8.06e-04 | 421 | 109 | 9 | IPR003599 | |
| Domain | Ig_I-set | 8.71e-04 | 190 | 109 | 6 | IPR013098 | |
| Domain | I-set | 8.71e-04 | 190 | 109 | 6 | PF07679 | |
| Domain | Pkinase_Tyr | 9.57e-04 | 129 | 109 | 5 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.29e-03 | 138 | 109 | 5 | IPR001245 | |
| Domain | PROTEIN_KINASE_ATP | 1.47e-03 | 459 | 109 | 9 | PS00107 | |
| Domain | - | 1.70e-03 | 663 | 109 | 11 | 2.60.40.10 | |
| Domain | Tyr_kinase_cat_dom | 1.76e-03 | 88 | 109 | 4 | IPR020635 | |
| Domain | TyrKc | 1.76e-03 | 88 | 109 | 4 | SM00219 | |
| Domain | GFP-like | 1.79e-03 | 11 | 109 | 2 | IPR023413 | |
| Domain | - | 1.79e-03 | 11 | 109 | 2 | 2.40.155.10 | |
| Domain | TPR-contain_dom | 1.87e-03 | 150 | 109 | 5 | IPR013026 | |
| Domain | ABC_transporter_CS | 1.88e-03 | 42 | 109 | 3 | IPR017871 | |
| Domain | TPR_1 | 1.91e-03 | 90 | 109 | 4 | IPR001440 | |
| Domain | TPR_1 | 1.91e-03 | 90 | 109 | 4 | PF00515 | |
| Domain | APOBEC_N | 2.14e-03 | 12 | 109 | 2 | PF08210 | |
| Domain | APOBEC_N | 2.14e-03 | 12 | 109 | 2 | IPR013158 | |
| Domain | Prot_kinase_dom | 2.26e-03 | 489 | 109 | 9 | IPR000719 | |
| Domain | IG_LIKE | 2.33e-03 | 491 | 109 | 9 | PS50835 | |
| Domain | PROTEIN_KINASE_DOM | 2.39e-03 | 493 | 109 | 9 | PS50011 | |
| Domain | ABC_tran | 2.76e-03 | 48 | 109 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 2.76e-03 | 48 | 109 | 3 | PS50893 | |
| Domain | Ig-like_fold | 2.78e-03 | 706 | 109 | 11 | IPR013783 | |
| Domain | TPR_REGION | 2.83e-03 | 165 | 109 | 5 | PS50293 | |
| Domain | TPR | 2.83e-03 | 165 | 109 | 5 | PS50005 | |
| Domain | ABC_TRANSPORTER_1 | 2.93e-03 | 49 | 109 | 3 | PS00211 | |
| Domain | FN_type2_col-bd | 2.93e-03 | 14 | 109 | 2 | IPR000562 | |
| Domain | FN2_2 | 2.93e-03 | 14 | 109 | 2 | PS51092 | |
| Domain | FN2_1 | 2.93e-03 | 14 | 109 | 2 | PS00023 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 2.93e-03 | 14 | 109 | 2 | IPR016192 | |
| Domain | fn2 | 2.93e-03 | 14 | 109 | 2 | PF00040 | |
| Domain | FN2 | 2.93e-03 | 14 | 109 | 2 | SM00059 | |
| Domain | WH2 | 2.93e-03 | 14 | 109 | 2 | SM00246 | |
| Domain | ABC_transporter-like | 3.10e-03 | 50 | 109 | 3 | IPR003439 | |
| Domain | CUB | 3.66e-03 | 53 | 109 | 3 | PS01180 | |
| Domain | WH2 | 3.84e-03 | 16 | 109 | 2 | PF02205 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 4.33e-03 | 17 | 109 | 2 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 4.33e-03 | 17 | 109 | 2 | IPR002125 | |
| Domain | Cytidine_deaminase-like | 4.33e-03 | 17 | 109 | 2 | IPR016193 | |
| Domain | Kinase-like_dom | 4.47e-03 | 542 | 109 | 9 | IPR011009 | |
| Domain | CUB_dom | 4.50e-03 | 57 | 109 | 3 | IPR000859 | |
| Pubmed | FAM193B MIA3 LIMD1 ATG2B RGPD1 TNRC6B MYPN COBL MTCL1 SIPA1L2 SUFU WIPI2 | 5.79e-12 | 209 | 115 | 12 | 36779422 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 3.94e-09 | 7 | 115 | 4 | 15710750 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP SEMA6C FAM193B CRYBG2 MYO10 NICN1 OBSCN GEMIN5 TBC1D25 IRS1 REV3L TTC3 MYOF PSME4 COBL SIPA1L2 SUFU | 1.42e-07 | 1105 | 115 | 17 | 35748872 |
| Pubmed | CACNA1C EPRS1 MYH2 MYH8 MYH13 RGPD8 STAG1 SMCHD1 RGPD1 U2AF2 TTC3 ANTXR2 SACS SH3PXD2A FAM186A RGPD3 ABCC2 SIPA1L2 RGPD5 | 2.65e-07 | 1442 | 115 | 19 | 35575683 | |
| Pubmed | 3.24e-07 | 197 | 115 | 8 | 36604605 | ||
| Pubmed | 6.28e-07 | 215 | 115 | 8 | 35973513 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 6.99e-07 | 6 | 115 | 3 | 10077619 | |
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 9710204 | ||
| Pubmed | 1.15e-06 | 24 | 115 | 4 | 25825872 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 9037092 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.22e-06 | 7 | 115 | 3 | 11353387 | |
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 30944974 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.22e-06 | 7 | 115 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.22e-06 | 7 | 115 | 3 | 17372272 | |
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 38657106 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 21205196 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 18949001 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 25187515 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 35210422 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 8603673 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 26632511 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 24403063 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 23818861 | ||
| Pubmed | SHC and SHIP phosphorylation and interaction in response to activation of the FLT3 receptor. | 1.22e-06 | 7 | 115 | 3 | 10482988 | |
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 23536549 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 12191015 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 22821000 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.95e-06 | 8 | 115 | 3 | 21670213 | |
| Pubmed | 1.95e-06 | 8 | 115 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.95e-06 | 8 | 115 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.95e-06 | 8 | 115 | 3 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.95e-06 | 8 | 115 | 3 | 28745977 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH2 MYH8 ILK MYH13 SRC INSR LCK TEC MYOF ABCE1 SH3PXD2A NKTR CDK11B REPS2 | 1.97e-06 | 910 | 115 | 14 | 36736316 |
| Pubmed | MIA3 LIMD1 PBK TNRC6B GIGYF1 NCKAP5L SH3PXD2A AFDN MTCL1 SIPA1L2 | 2.44e-06 | 446 | 115 | 10 | 24255178 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 2.92e-06 | 9 | 115 | 3 | 18394993 | |
| Pubmed | 2.92e-06 | 9 | 115 | 3 | 28100513 | ||
| Pubmed | 2.92e-06 | 9 | 115 | 3 | 17887960 | ||
| Pubmed | 2.92e-06 | 9 | 115 | 3 | 11553612 | ||
| Pubmed | 2.92e-06 | 9 | 115 | 3 | 10601307 | ||
| Pubmed | 2.92e-06 | 9 | 115 | 3 | 10455176 | ||
| Pubmed | 2.92e-06 | 9 | 115 | 3 | 9733766 | ||
| Pubmed | 2.92e-06 | 9 | 115 | 3 | 28877029 | ||
| Pubmed | 4.16e-06 | 10 | 115 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 4.16e-06 | 10 | 115 | 3 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 4.16e-06 | 10 | 115 | 3 | 8857542 | |
| Pubmed | 4.16e-06 | 10 | 115 | 3 | 21859863 | ||
| Pubmed | 5.70e-06 | 11 | 115 | 3 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 5.70e-06 | 11 | 115 | 3 | 35771867 | |
| Pubmed | 5.70e-06 | 11 | 115 | 3 | 34110283 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ITCH ILK LIMD1 IRS1 GIGYF1 LCK PAK6 NCKAP5L SH3PXD2A COBL AFDN MTCL1 SIPA1L2 | 5.74e-06 | 861 | 115 | 13 | 36931259 |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 9.83e-06 | 13 | 115 | 3 | 31427429 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15013951 | ||
| Pubmed | Tks5-dependent formation of circumferential podosomes/invadopodia mediates cell-cell fusion. | 1.08e-05 | 2 | 115 | 2 | 22584907 | |
| Pubmed | Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. | 1.08e-05 | 2 | 115 | 2 | 9038347 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15590636 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19607904 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19560437 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 27016416 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 12765966 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 18252715 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 21204696 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 8448209 | ||
| Pubmed | A Src-Tks5 pathway is required for neural crest cell migration during embryonic development. | 1.08e-05 | 2 | 115 | 2 | 21799874 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 25667086 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 9687503 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 10455177 | ||
| Pubmed | Tks5 SH3 domains exhibit differential effects on invadopodia development. | 1.08e-05 | 2 | 115 | 2 | 31999741 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 17593353 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 7935368 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 7685110 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15182363 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 14581460 | ||
| Pubmed | 1.14e-05 | 228 | 115 | 7 | 30471916 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ILK RGPD8 SMCHD1 RGPD1 U2AF2 ABCE1 RGPD3 PYGL AFDN CDK11B GAPDHS | 1.36e-05 | 665 | 115 | 11 | 30457570 |
| Pubmed | EPRS1 LIMD1 SMCHD1 ATG2B TNRC6B GEMIN5 AFDN PLS3 WIPI2 RGPD5 | 1.50e-05 | 549 | 115 | 10 | 38280479 | |
| Pubmed | 1.56e-05 | 15 | 115 | 3 | 14697343 | ||
| Pubmed | DAB2IP SHANK1 MIA3 ITCH RGPD8 SRC RGPD1 ADGRB3 TNRC6B TTC3 RGPD3 AFDN MTCL1 | 1.88e-05 | 963 | 115 | 13 | 28671696 | |
| Pubmed | 2.02e-05 | 99 | 115 | 5 | 27746211 | ||
| Pubmed | Substrate-trapping techniques in the identification of cellular PTP targets. | 2.14e-05 | 49 | 115 | 4 | 15588985 | |
| Pubmed | DAB2IP SHANK1 EPRS1 MIA3 RGPD8 COX4I1 ATG2B RGPD1 ADGRB3 TNRC6B ABCE1 RGPD3 AFDN SIPA1L2 | 2.48e-05 | 1139 | 115 | 14 | 36417873 | |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 3.00e-05 | 265 | 115 | 7 | 19240061 | |
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 3.24e-05 | 3 | 115 | 2 | 27602762 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 28427417 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 27529678 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 22691411 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 3.24e-05 | 3 | 115 | 2 | 22666481 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 9792645 | ||
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 3.24e-05 | 3 | 115 | 2 | 16648136 | |
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 3.24e-05 | 3 | 115 | 2 | 23533681 | |
| Pubmed | PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities. | 3.24e-05 | 3 | 115 | 2 | 7499194 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 23315078 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 15372107 | ||
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 3.24e-05 | 3 | 115 | 2 | 25589647 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 19273608 | ||
| Pubmed | Direct interaction between ER membrane-bound PTP1B and its plasma membrane-anchored targets. | 3.24e-05 | 3 | 115 | 2 | 17092689 | |
| Pubmed | XB130/Tks5 scaffold protein interaction regulates Src-mediated cell proliferation and survival. | 3.24e-05 | 3 | 115 | 2 | 26446840 | |
| Pubmed | The APOBEC3C crystal structure and the interface for HIV-1 Vif binding. | 3.24e-05 | 3 | 115 | 2 | 23001005 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 18716398 | ||
| Interaction | GSK3A interactions | FAM193B MIA3 LIMD1 ATG2B RGPD1 TNRC6B U2AF2 MYPN COBL MTCL1 SIPA1L2 SUFU WIPI2 | 2.05e-06 | 464 | 113 | 13 | int:GSK3A |
| Interaction | PTPRC interactions | 2.44e-06 | 69 | 113 | 6 | int:PTPRC | |
| Interaction | NPIPB6 interactions | 2.70e-06 | 18 | 113 | 4 | int:NPIPB6 | |
| Interaction | RGPD4 interactions | 6.34e-06 | 22 | 113 | 4 | int:RGPD4 | |
| Interaction | GSK3B interactions | FAM193B MIA3 ILK LIMD1 ATG2B RGPD1 TNRC6B IRS1 MYOF ABCE1 MYPN COBL PYGL MTCL1 SIPA1L2 SUFU WIPI2 | 6.71e-06 | 868 | 113 | 17 | int:GSK3B |
| Interaction | RGPD2 interactions | 1.49e-05 | 27 | 113 | 4 | int:RGPD2 | |
| Interaction | MEX3B interactions | 3.63e-05 | 222 | 113 | 8 | int:MEX3B | |
| Interaction | ATXN2 interactions | 6.64e-05 | 312 | 113 | 9 | int:ATXN2 | |
| Interaction | AMOT interactions | 6.64e-05 | 312 | 113 | 9 | int:AMOT | |
| Interaction | FBXW11 interactions | EPRS1 FAM193B MYO10 MTSS1 MTMR1 GEMIN5 IRS1 NCKAP5L MRPS23 COBL SIPA1L2 | 7.16e-05 | 473 | 113 | 11 | int:FBXW11 |
| Interaction | SH3PXD2A interactions | 8.46e-05 | 128 | 113 | 6 | int:SH3PXD2A | |
| Cytoband | 20q12-q13 | 6.22e-06 | 2 | 115 | 2 | 20q12-q13 | |
| Cytoband | 21q21.2 | 1.30e-04 | 7 | 115 | 2 | 21q21.2 | |
| Cytoband | 2q13 | 6.82e-04 | 68 | 115 | 3 | 2q13 | |
| Cytoband | 5q33.2 | 7.29e-04 | 16 | 115 | 2 | 5q33.2 | |
| Cytoband | 22q13.1 | 1.30e-03 | 85 | 115 | 3 | 22q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q24 | 1.35e-03 | 189 | 115 | 4 | chr10q24 | |
| Cytoband | 1p22.3 | 1.39e-03 | 22 | 115 | 2 | 1p22.3 | |
| GeneFamily | Myosin heavy chains | 4.70e-05 | 15 | 87 | 3 | 1098 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 5.76e-05 | 16 | 87 | 3 | 66 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.27e-04 | 161 | 87 | 6 | 593 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.33e-04 | 115 | 87 | 5 | 769 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 1.46e-03 | 12 | 87 | 2 | 406 | |
| GeneFamily | ATP binding cassette subfamily C | 1.72e-03 | 13 | 87 | 2 | 807 | |
| GeneFamily | Immunoglobulin like domain containing | 2.40e-03 | 193 | 87 | 5 | 594 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 3.71e-03 | 19 | 87 | 2 | 909 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 4.11e-03 | 20 | 87 | 2 | 736 | |
| GeneFamily | Fibronectin type III domain containing | 7.44e-03 | 160 | 87 | 4 | 555 | |
| Coexpression | GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP | 1.06e-05 | 172 | 114 | 7 | M2945 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 1.26e-05 | 33 | 114 | 4 | MM477 | |
| Coexpression | GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP | 2.71e-05 | 199 | 114 | 7 | M7491 | |
| Coexpression | GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_UP | 2.80e-05 | 200 | 114 | 7 | M8097 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP | 2.80e-05 | 200 | 114 | 7 | M9895 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.96e-08 | 193 | 115 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 5.22e-08 | 200 | 115 | 8 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.44e-07 | 180 | 115 | 7 | fd8c2059fcb382ffbfe19e598e37a49e1d5637b5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.61e-07 | 181 | 115 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.79e-07 | 182 | 115 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-07 | 186 | 115 | 7 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.75e-07 | 187 | 115 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.95e-07 | 188 | 115 | 7 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.17e-07 | 189 | 115 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.62e-07 | 191 | 115 | 7 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.10e-07 | 193 | 115 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.10e-07 | 193 | 115 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.35e-07 | 194 | 115 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.35e-07 | 194 | 115 | 7 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.35e-07 | 194 | 115 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 7.35e-07 | 194 | 115 | 7 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.61e-07 | 195 | 115 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 7.61e-07 | 195 | 115 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 7.61e-07 | 195 | 115 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.61e-07 | 195 | 115 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.61e-07 | 195 | 115 | 7 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.15e-07 | 197 | 115 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.15e-07 | 197 | 115 | 7 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 8.15e-07 | 197 | 115 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 8.15e-07 | 197 | 115 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.43e-07 | 198 | 115 | 7 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.43e-07 | 198 | 115 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.72e-07 | 199 | 115 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.72e-07 | 199 | 115 | 7 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.72e-07 | 199 | 115 | 7 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.72e-07 | 199 | 115 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.02e-07 | 200 | 115 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.02e-07 | 200 | 115 | 7 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.02e-07 | 200 | 115 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.02e-07 | 200 | 115 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.02e-07 | 200 | 115 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 9.02e-07 | 200 | 115 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 9.02e-07 | 200 | 115 | 7 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.02e-07 | 200 | 115 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.63e-06 | 159 | 115 | 6 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.15e-06 | 169 | 115 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.89e-06 | 173 | 115 | 6 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.40e-06 | 180 | 115 | 6 | 5391d23817f5cc88a0871ddb98968897c839f464 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-06 | 181 | 115 | 6 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-06 | 182 | 115 | 6 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.88e-06 | 182 | 115 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.38e-06 | 184 | 115 | 6 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.65e-06 | 185 | 115 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.92e-06 | 186 | 115 | 6 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.92e-06 | 186 | 115 | 6 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.19e-06 | 187 | 115 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.19e-06 | 187 | 115 | 6 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 9.19e-06 | 187 | 115 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.48e-06 | 188 | 115 | 6 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.48e-06 | 188 | 115 | 6 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 9.77e-06 | 189 | 115 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.77e-06 | 189 | 115 | 6 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.77e-06 | 189 | 115 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.01e-05 | 190 | 115 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.01e-05 | 190 | 115 | 6 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.01e-05 | 190 | 115 | 6 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 190 | 115 | 6 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 1.01e-05 | 190 | 115 | 6 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-05 | 190 | 115 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.01e-05 | 190 | 115 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-05 | 191 | 115 | 6 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.04e-05 | 191 | 115 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.04e-05 | 191 | 115 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.07e-05 | 192 | 115 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.07e-05 | 192 | 115 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.10e-05 | 193 | 115 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.13e-05 | 194 | 115 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.13e-05 | 194 | 115 | 6 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.13e-05 | 194 | 115 | 6 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 1.17e-05 | 195 | 115 | 6 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.17e-05 | 195 | 115 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.17e-05 | 195 | 115 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.17e-05 | 195 | 115 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.17e-05 | 195 | 115 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-05 | 195 | 115 | 6 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 1.17e-05 | 195 | 115 | 6 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.20e-05 | 196 | 115 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.20e-05 | 196 | 115 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.24e-05 | 197 | 115 | 6 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.24e-05 | 197 | 115 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 197 | 115 | 6 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.27e-05 | 198 | 115 | 6 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-05 | 198 | 115 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.27e-05 | 198 | 115 | 6 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-05 | 198 | 115 | 6 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.31e-05 | 199 | 115 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.31e-05 | 199 | 115 | 6 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-05 | 199 | 115 | 6 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.35e-05 | 200 | 115 | 6 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.35e-05 | 200 | 115 | 6 | f75d95376a340d467c4392b872b2a2dbdd184556 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.35e-05 | 200 | 115 | 6 | fae26560ba3b0b638b6bcf92f05330824b31d21b | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| Drug | blebbistatin | 1.95e-06 | 116 | 114 | 7 | CID003476986 | |
| Drug | NSC339663 | 4.78e-06 | 250 | 114 | 9 | CID000003892 | |
| Drug | formycin triphosphate | 5.63e-06 | 51 | 114 | 5 | CID000122274 | |
| Drug | 6-methoxypurine arabinoside | 5.86e-06 | 24 | 114 | 4 | CID000124757 | |
| Drug | AC1NRBPQ | 5.90e-06 | 137 | 114 | 7 | CID005288569 | |
| Drug | purealin | 1.07e-05 | 58 | 114 | 5 | CID006419303 | |
| Drug | 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine | 2.49e-05 | 2 | 114 | 2 | DB03023 | |
| Drug | B0683 | 2.75e-05 | 117 | 114 | 6 | CID006398969 | |
| Drug | Chromium Compounds | 3.37e-05 | 13 | 114 | 3 | ctd:D017608 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.14e-07 | 13 | 107 | 4 | DOID:397 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 5.46e-06 | 10 | 107 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 5.46e-06 | 10 | 107 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 5.46e-06 | 10 | 107 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 5.46e-06 | 10 | 107 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 5.46e-06 | 10 | 107 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 5.46e-06 | 10 | 107 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 5.46e-06 | 10 | 107 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 5.46e-06 | 10 | 107 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 9.96e-06 | 12 | 107 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 9.96e-06 | 12 | 107 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.04e-05 | 15 | 107 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 2.81e-05 | 48 | 107 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | secretory phospholipase A2 receptor measurement | 3.90e-05 | 3 | 107 | 2 | EFO_0802043 | |
| Disease | Hypertrophic Cardiomyopathy | 5.57e-05 | 57 | 107 | 4 | C0007194 | |
| Disease | tyrosine-protein kinase TEC measurement | 7.78e-05 | 4 | 107 | 2 | EFO_0020830 | |
| Disease | YKL40 measurement, cerebrospinal fluid biomarker measurement | 1.29e-04 | 5 | 107 | 2 | EFO_0004869, EFO_0006794 | |
| Disease | periodontitis | 1.67e-04 | 223 | 107 | 6 | EFO_0000649 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.09e-04 | 80 | 107 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 2.41e-04 | 702 | 107 | 10 | C0009402 | |
| Disease | myositis | 3.85e-04 | 39 | 107 | 3 | EFO_0000783 | |
| Disease | dickkopf‐related protein 1 measurement | 8.40e-04 | 12 | 107 | 2 | EFO_0010620 | |
| Disease | corpus callosum posterior volume measurement | 9.00e-04 | 52 | 107 | 3 | EFO_0010298 | |
| Disease | childhood onset asthma | 1.39e-03 | 334 | 107 | 6 | MONDO_0005405 | |
| Disease | susceptibility to hepatitis B infection measurement | 1.64e-03 | 64 | 107 | 3 | EFO_0008405 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 1.71e-03 | 17 | 107 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | sphingomyelin 14:0 measurement | 1.71e-03 | 17 | 107 | 2 | EFO_0010390 | |
| Disease | polychlorinated biphenyls measurement | 1.72e-03 | 65 | 107 | 3 | EFO_0007042 | |
| Disease | neuroimaging measurement | SEMA4D ITCH STAG1 RGPD1 LAMA2 TNRC6B REV3L PAK6 PPWD1 SH3PXD2A IQCJ-SCHIP1 | 1.74e-03 | 1069 | 107 | 11 | EFO_0004346 |
| Disease | breast carcinoma (is_marker_for) | 1.80e-03 | 66 | 107 | 3 | DOID:3459 (is_marker_for) | |
| Disease | body fat percentage | 2.04e-03 | 488 | 107 | 7 | EFO_0007800 | |
| Disease | body weight | AKAP6 CACNA1C SMCHD1 INSR RGPD1 ADGRB3 TNRC6B IRS1 PAK6 PTPRT NEGR1 ZFHX3 | 2.07e-03 | 1261 | 107 | 12 | EFO_0004338 |
| Disease | cystathionine measurement | 2.14e-03 | 19 | 107 | 2 | EFO_0010474 | |
| Disease | age at onset, Myopia | 2.21e-03 | 150 | 107 | 4 | EFO_0004847, HP_0000545 | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 2.22e-03 | 71 | 107 | 3 | EFO_0004735, EFO_0007965 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.22e-03 | 71 | 107 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | end stage renal disease (implicated_via_orthology) | 2.37e-03 | 20 | 107 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | executive function measurement | 2.53e-03 | 376 | 107 | 6 | EFO_0009332 | |
| Disease | Paroxysmal atrial fibrillation | 2.54e-03 | 156 | 107 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 2.54e-03 | 156 | 107 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.54e-03 | 156 | 107 | 4 | C2585653 | |
| Disease | intraocular pressure measurement | 2.58e-03 | 509 | 107 | 7 | EFO_0004695 | |
| Disease | Atrial Fibrillation | 2.79e-03 | 160 | 107 | 4 | C0004238 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 3.46e-03 | 170 | 107 | 4 | EFO_0000685, EFO_0007791, EFO_0007837 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPWAEYSEPKKLPGD | 1146 | P55196 | |
| PDFNPFKWLKPVRGS | 446 | Q9NX77 | |
| FVYSDDEPFKPWKGL | 356 | Q96AK3 | |
| YPEPYPPGKECDWKV | 1461 | Q7Z408 | |
| NKNPWDTFKNPSEYP | 1466 | O60242 | |
| EPLPTKKWPTVDASY | 366 | P58335 | |
| FKDLGTPSEKIWPGY | 651 | P21127 | |
| EFKIWKSNYVPPPET | 96 | Q8N6N3 | |
| PEDVYIYKPPVSKPW | 146 | Q8IWG1 | |
| EPKLSPSWNPKIIYE | 251 | Q96BY7 | |
| FKDWNIPFKQPSYPS | 131 | Q9BYG3 | |
| KFPINGWKVYDPVSE | 221 | Q13613 | |
| INYTFKTPEKEPPLW | 1631 | Q99666 | |
| INYTFKTPEKEPPLW | 1631 | O14715 | |
| PAVEWIPKYAGVSPK | 641 | Q9UHI8 | |
| LSKFKFEPPREPGWL | 666 | Q9Y4B5 | |
| FVEKWYPVVTPNPKG | 306 | Q5VWQ8 | |
| FDPKEGKFVGLPPQW | 26 | Q9NQU5 | |
| KWFYKDPQGEIQGPF | 476 | O75420 | |
| VDPQPWFQDGPKSYL | 331 | Q9UGP4 | |
| PPPAFEWYKGEKKLF | 251 | Q7Z3B1 | |
| KSWREPKPEYGDFQP | 1041 | Q9HCH0 | |
| KIAWDLPKFYPPVEP | 441 | Q86SR1 | |
| PFPEDYGKQPKLWLC | 196 | Q9H7Z6 | |
| YKEGDPAPYKNPERW | 146 | Q9HCN6 | |
| VTVNPYKWLPVYKPE | 126 | P13535 | |
| DWSKVNKPPYPKLGA | 441 | P13797 | |
| LQPPKGYKEEEFSWS | 371 | Q9Y468 | |
| IPSWKDWAKPGPYDQ | 406 | O43312 | |
| VNPYKWLPVYKPEVV | 126 | Q9UKX2 | |
| VPPDEKIFKETGYWN | 1451 | Q9HD67 | |
| QIPKGRTPKTPDWYN | 791 | O60449 | |
| KFPIKWTAPEAINYG | 401 | P06239 | |
| EPFYWKLPEQFEGKK | 1231 | P24043 | |
| PPDWPSKGKIQFNNY | 1291 | Q92887 | |
| KWKPPSDPNGNITHY | 641 | P06213 | |
| QDKEGNPAPEYTWFK | 156 | P57087 | |
| YGDVPPGPAFKEVWQ | 151 | P35568 | |
| YQSINPKDPSAKPKW | 96 | Q8TAC1 | |
| WFDFGLPFPPEKRAK | 211 | Q96RP7 | |
| KEPPVFKGDYPSNWI | 4346 | Q96RW7 | |
| PQKDYWGFLTPMTVP | 456 | Q8NFY9 | |
| GPFEEKIYIQWKPPN | 496 | O14522 | |
| TKFPGPKSIPDYWDS | 476 | Q9H0J9 | |
| PKAVQWYKDDTPLSP | 2496 | Q5VST9 | |
| ENKKNWFGPSPYVEV | 31 | Q96J02 | |
| FKTPEKEPPLWYAEF | 1636 | A6NKT7 | |
| NDDEPFKPWKGLKYN | 346 | Q8IUX4 | |
| KQKPNLGKYDDPPDW | 126 | P61221 | |
| WNSPKPEYFLGSVDK | 116 | A0A1B0GVN3 | |
| IAFKPKGYFSDPWNV | 1291 | Q13936 | |
| LFFKDKEPVPWEFPS | 396 | Q9UFH2 | |
| VIWVKTPKPGYPSSE | 676 | Q96PV7 | |
| EKTPVYMNFSDPGPW | 896 | Q6ZRK6 | |
| PAALFPTWKEVVKGP | 521 | Q8N1P7 | |
| DSIWPPSIFGPKKKF | 1081 | O75128 | |
| WAYGKKGQPDAKIPP | 196 | Q00688 | |
| YAPAWVAPEALQKKP | 351 | Q13418 | |
| WFPPGYPEAKKVAEE | 101 | Q8IX06 | |
| PKYFPEPELFKPERW | 376 | Q9NYL5 | |
| KWEYVPLGPFLGKSF | 241 | P16930 | |
| PLEWYQKSRFPPIDK | 2061 | A6NE01 | |
| KEPKQIPWRAVGSPY | 151 | O14556 | |
| YGPLPQSFDKEWVAK | 126 | P13073 | |
| FYPPPLLDWKVTQEK | 391 | Q86YT5 | |
| QAKGVPPPSITWYKD | 331 | Q58EX2 | |
| KERPPNYPGSLVWKG | 1161 | Q9NZJ4 | |
| PKLTKPDSATGPQWY | 16 | Q3KNS1 | |
| INYTFKTPEKEPPLW | 1616 | P0DJD0 | |
| WEQFNPTKYTFFPPK | 206 | Q8N2A8 | |
| KEKPLWFDVYDAFPP | 26 | Q9Y3D9 | |
| PWDPKYEAKAGPRPV | 6 | Q8TEE9 | |
| KFPIKWTAPEAALYG | 426 | P12931 | |
| SIWDPGYEEFPKSQK | 561 | Q695T7 | |
| NPEVGLKPVWYSPKV | 536 | P07814 | |
| PDLPSKKQGPWATYA | 586 | A6NHR9 | |
| WSYGEDVKPFKPPLS | 186 | Q3MII6 | |
| DDVQPGPDFYGLPWK | 1166 | Q5JRA6 | |
| KFPVKWCPPEVFNYS | 526 | P42680 | |
| PGQKPWKPSYERIQE | 621 | P30414 | |
| LEFIGDPKPPAWKGY | 336 | O95255 | |
| TGPPHEYKFPKNVNW | 251 | Q96BP3 | |
| YQQGPKSPSVTFPKW | 136 | Q9BSH3 | |
| YVIGWKKSEGSPPPE | 1396 | Q9P2F8 | |
| KEKPPEEPTTWTGYF | 281 | Q9Y4P8 | |
| SHTKWVRYNGPVPKP | 351 | Q92854 | |
| PFPVYQKKVIDEWAP | 156 | B3KU38 | |
| EKGVWSQPYPVCEPL | 3106 | Q4LDE5 | |
| TGEYTWKPVGQKPEP | 586 | Q13018 | |
| WKPVGQKPEPVQYTH | 591 | Q13018 | |
| PDKPFGAKPLGFWTK | 2086 | Q9Y566 | |
| QYEKPPPLHTGADWK | 51 | Q13023 | |
| PEYLQAAFPKPKWDC | 366 | Q8NFH8 | |
| KDFWPKVPDSPATKY | 1021 | O60673 | |
| GQDVPLKPDAEYPEW | 81 | Q6P161 | |
| EYPEWLFEMNLGPPK | 91 | Q6P161 | |
| GVKPFKGWVPSNYLE | 1116 | Q5TCZ1 | |
| AKFPESIKAWPFPDV | 1446 | Q8TEQ6 | |
| TSPEEFKLPKEYSWP | 451 | Q9UMX1 | |
| ITSPGWPKEYPTNKN | 631 | Q9Y6L7 | |
| PKPVLEDVKPTYWAQ | 1296 | P53804 | |
| VNPYKWLPVYKPEVV | 126 | Q9UKX3 | |
| GPQPPLRSAKYDSKW | 206 | Q9H3T2 | |
| DYPLTMPGPQWKKFR | 161 | Q8WVM7 | |
| DPEACYIGTEPWKPK | 201 | Q96KB5 | |
| PPSEYFPIKDWGKPG | 746 | Q14997 | |
| IDPSFQWYGPKGKVV | 96 | Q9BS86 | |
| YLNWKGPASAKAEPP | 436 | Q53FD0 | |
| KKVRKYWDVPPPGFE | 86 | P26368 | |
| PDYKSFCREEKEWPP | 96 | Q9UJW2 | |
| YGNPWEKSRPEFMLP | 186 | P06737 | |
| KFPDYKSTWSPDPIG | 1561 | Q9UPQ9 | |
| PEPPKQEYWGSKRSS | 2231 | Q15911 | |
| FPLPFVKPENKFWPT | 971 | P23378 | |
| KGWEYGITIPPDHKP | 991 | Q9NZM1 | |
| IGMPPPVFYWKKDNE | 1196 | Q86TC9 |